Skip to main content

Siren, L.L.C.

13F filer · CIK 0002005245
Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$4.94BU.S. long equity reported on 13F
Positions11524 new · 9 closed
Net flow last quarter+$341MBuys minus sells
Top 10 positions weight44.6%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 2026115 positions
SRRKScholar Rock Holding Corp$527M10.66%7.87%-11.6%Q3 2024
KYMRKymera Therapeutics, Inc.$337M6.81%3.55%-7.9%Q3 2024
ERASErasca, Inc.$209M4.23%3.65%+1.4%Q3 2024
MANEVeradermics, Inc$204M4.12%3.96%+10.0%Q1 2026
TNGXTango Therapeutics, Inc.$193M3.91%3.67%+9.2%Q3 2024
RVMDRevolution Medicines, Inc.$169M3.41%0.42%-19.0%Q3 2024
BCAXBicara Therapeutics Inc.$166M3.37%8.50%-3.5%Q3 2024
ARWRArrowhead Pharmaceuticals, Inc.$140M2.83%1.22%+6.2%Q3 2024
ONCBeOne Medicines Ltd.$133M2.68%0.03%Not reportedQ3 2024
EWTXEdgewise Therapeutics, Inc.$129M2.62%2.95%-28.1%Q3 2024
RYTMRhythm Pharmaceuticals, Inc.$126M2.55%1.65%+56.6%Q1 2025
LXRXLexicon Pharmaceuticals, Inc.$106M2.15%9.91%Not reportedQ3 2024
ELVNEnliven Therapeutics, Inc.$90.1M1.82%2.42%+137.8%Q1 2026
SYRESpyre Therapeutics, Inc.$86M1.74%1.10%+18.3%Q4 2024
PBLSParabilis Medicines, Inc.$81.9M1.66%2.45%NewQ2 2026
XENEXenon Pharmaceuticals Inc.$79.6M1.61%1.36%Not reportedQ3 2024
SLDBSolid Biosciences Inc.$76.8M1.55%7.32%Not reportedQ3 2024
ABVXAbivax S.A.$76.8M1.55%0.73%NewQ2 2026
COAGHemab Therapeutics Holdings, Inc.$76.6M1.55%4.47%NewQ2 2026
RCUSArcus Biosciences, Inc.$74.6M1.51%1.91%-19.5%Q3 2024
COGTCogent Biosciences, Inc.$72M1.46%1.08%+8.8%Q2 2025
RLAYRelay Therapeutics, Inc.$68.3M1.38%1.67%NewQ2 2026
TSHATaysha Gene Therapies, Inc.$67.1M1.36%3.03%+11.5%Q3 2024
DFTXDefinium Therapeutics, Inc.$66.8M1.35%1.06%+54.4%Q1 2026
STOKStoke Therapeutics, Inc.$65.3M1.32%3.20%Not reportedQ4 2024
IRONDisc Medicine, Inc.$65M1.31%2.32%-10.1%Q1 2025
CYTKCytokinetics Inc$64.7M1.31%0.61%+23.6%Q3 2024
SEPNSepterna, Inc.$63.6M1.29%4.16%-5.0%Q4 2024
OLMAOlema Pharmaceuticals, Inc.$60.8M1.23%5.55%+2.1%Q4 2025
CRNXCrinetics Pharmaceuticals, Inc.$53.2M1.08%1.34%-25.4%Q3 2024
KLRAKailera Therapeutics, Inc.$48.8M0.99%1.71%NewQ2 2026
DYNDyne Therapeutics, Inc.$47.3M0.96%1.29%-4.5%Q3 2024
GPCRStructure Therapeutics Inc.$46.9M0.95%0.41%-34.3%Q3 2025
TBLATaboola.com Ltd.$42.1M0.85%2.51%-15.5%Q3 2024
PVLAPalvella Therapeutics, Inc.$39.3M0.80%1.79%Not reportedQ4 2025
SLNSilence Therapeutics plc$36.4M0.74%2.34%+13.7%Q3 2024
DNLIDenali Therapeutics Inc.$35.9M0.73%0.87%Not reportedQ3 2024
RELYRemitly Global, Inc.$34.6M0.70%0.73%Not reportedQ3 2024
CGEMCullinan Therapeutics, Inc.$34.5M0.70%2.94%+58.7%Q3 2024
COFCapital One Financial Corp$34.4M0.70%0.03%NewQ2 2026
TRVITrevi Therapeutics, Inc.$33.3M0.67%1.25%Not reportedQ4 2024
ORICOric Pharmaceuticals, Inc.$32.5M0.66%2.89%Not reportedQ3 2024
GOOGLAlphabet Inc.$32.2M0.65%0.00%+37.0%Q3 2024
DBVTDBV Technologies S.A.$30.5M0.62%0.63%Not reportedQ4 2025
ABSIAbsci Corp$28.7M0.58%1.59%+37.5%Q1 2026
SIONSionna Therapeutics, Inc.$26.9M0.54%1.35%+103.5%Q1 2025
RAPPRapport Therapeutics, Inc.$26.7M0.54%1.34%Not reportedQ3 2024
AMLXAmylyx Pharmaceuticals, Inc.$26.6M0.54%1.33%+20.4%Q1 2026
ANNXAnnexon, Inc.$25.5M0.52%2.99%+12.6%Q1 2026
MNPRMonopar Therapeutics$25M0.51%4.02%Not reportedQ4 2025
Q1 2026Reported May 14, 2026100 positions
SRRKScholar Rock Holding Corp$532M14.75%9.09%Not reportedQ3 2024
KYMRKymera Therapeutics, Inc.$265M7.36%3.88%-3.0%Q3 2024
ERASErasca, Inc.$182M5.04%3.62%+28.4%Q3 2024
EWTXEdgewise Therapeutics, Inc.$140M3.87%4.12%-2.2%Q3 2024
ONCBeOne Medicines Ltd.$138M3.83%0.03%-7.0%Q3 2024
TNGXTango Therapeutics, Inc.$118M3.28%3.92%-30.7%Q3 2024
BCAXBicara Therapeutics Inc.$115M3.20%8.85%+11.2%Q3 2024
RVMDRevolution Medicines, Inc.$108M3.00%0.56%-16.8%Q3 2024
ARWRArrowhead Pharmaceuticals, Inc.$101M2.81%1.15%+7.7%Q3 2024
MANEVeradermics, Inc$95.1M2.64%4.03%NewQ1 2026
XENEXenon Pharmaceuticals Inc.$76.7M2.13%1.36%+62.2%Q3 2024
OLMAOlema Pharmaceuticals, Inc.$70.9M1.97%5.45%+44.1%Q4 2025
CRNXCrinetics Pharmaceuticals, Inc.$69.1M1.92%1.81%+26.3%Q3 2024
LXRXLexicon Pharmaceuticals, Inc.$69.1M1.92%10.41%+13.8%Q3 2024
COGTCogent Biosciences, Inc.$65.8M1.82%1.00%+4.9%Q2 2025
STOKStoke Therapeutics, Inc.$65M1.80%3.21%-11.2%Q4 2024
RCUSArcus Biosciences, Inc.$65M1.80%2.40%Not reportedQ3 2024
GPCRStructure Therapeutics Inc.$64M1.78%0.62%+23.2%Q3 2025
IRONDisc Medicine, Inc.$63.2M1.75%2.59%Not reportedQ1 2025
RYTMRhythm Pharmaceuticals, Inc.$63.1M1.75%1.06%+45.1%Q1 2025
SLDBSolid Biosciences Inc.$55.4M1.53%7.82%Not reportedQ3 2024
SEPNSepterna, Inc.$48.1M1.33%4.45%Not reportedQ4 2024
CNTACentessa Pharmaceuticals PLC$41.8M1.16%0.68%-73.8%Q3 2024
SYRESpyre Therapeutics, Inc.$41.3M1.14%1.04%Not reportedQ4 2024
CYTKCytokinetics Inc$40.5M1.12%0.50%Not reportedQ3 2024
DYNDyne Therapeutics, Inc.$40.4M1.12%1.35%-36.4%Q3 2024
TSHATaysha Gene Therapies, Inc.$39.5M1.09%3.07%-12.8%Q3 2024
DBVTDBV Technologies S.A.$38.8M1.08%0.63%Not reportedQ4 2025
ORICOric Pharmaceuticals, Inc.$38M1.05%2.90%+197.6%Q3 2024
ENGNenGene Therapeutics Inc.$35.8M0.99%7.84%+57.5%Q4 2025
PVLAPalvella Therapeutics, Inc.$32.1M0.89%1.80%+243.3%Q4 2025
TBLATaboola.com Ltd.$30.9M0.86%2.97%Not reportedQ3 2024
ELVNEnliven Therapeutics, Inc.$29.3M0.81%1.23%NewQ1 2026
DNLIDenali Therapeutics Inc.$26.8M0.74%0.88%Not reportedQ3 2024
RELYRemitly Global, Inc.$24.2M0.67%0.73%-4.6%Q3 2024
DMRADamora Therapeutics, Inc.$23.3M0.65%1.49%NewQ1 2026
ZURAZura Bio Ltd$22.2M0.62%3.94%+187.3%Q4 2025
ANNXAnnexon, Inc.$21.9M0.61%2.65%NewQ1 2026
TRVITrevi Therapeutics, Inc.$21.3M0.59%1.39%-21.9%Q4 2024
RAPPRapport Therapeutics, Inc.$20.1M0.56%1.34%-9.5%Q3 2024
GOOGLAlphabet Inc.$18.9M0.52%0.00%+217.4%Q3 2024
FULCFulcrum Therapeutics, Inc.$18M0.50%3.53%+20.5%Q4 2025
WVEWave Life Sciences, Inc.$17.8M0.49%1.27%Not reportedQ3 2024
DFTXDefinium Therapeutics, Inc.$17.4M0.48%0.88%NewQ1 2026
AMLXAmylyx Pharmaceuticals, Inc.$17.1M0.47%1.11%NewQ1 2026
CGEMCullinan Therapeutics, Inc.$17M0.47%1.94%Not reportedQ3 2024
NMRANeumora Therapeutics, Inc.$16.6M0.46%4.67%+35.1%Q3 2024
QUREuniQure N.V.$16.4M0.45%1.59%Not reportedQ3 2025
CTMXCytomX Therapeutics, Inc.$16.3M0.45%2.03%NewQ1 2026
NVDANvidia Corp$15.5M0.43%0.00%+137.7%Q3 2024
Q4 2025Reported Feb 13, 2026113 positions
SRRKScholar Rock Holding Corp$477M14.22%9.98%+17.0%Q3 2024
KYMRKymera Therapeutics, Inc.$256M7.63%4.04%-4.1%Q3 2024
ONCBeOne Medicines Ltd.$152M4.53%0.03%+1.4%Q3 2024
EWTXEdgewise Therapeutics, Inc.$112M3.35%4.26%+16.2%Q3 2024
RVMDRevolution Medicines, Inc.$106M3.17%0.68%+27.9%Q3 2024
CNTACentessa Pharmaceuticals PLC$101M3.00%2.70%+24.8%Q3 2024
ARWRArrowhead Pharmaceuticals, Inc.$99.6M2.97%1.09%-43.8%Q3 2024
BCAXBicara Therapeutics Inc.$87.8M2.62%9.22%Not reportedQ3 2024
OLMAOlema Pharmaceuticals, Inc.$82.5M2.46%4.06%NewQ4 2025
IRONDisc Medicine, Inc.$78.5M2.34%2.61%+8.2%Q1 2025
GPCRStructure Therapeutics Inc.$75M2.24%0.51%+5.1%Q3 2025
TNGXTango Therapeutics, Inc.$72.3M2.16%6.01%+38.8%Q3 2024
RCUSArcus Biosciences, Inc.$71.7M2.14%2.40%+3.3%Q3 2024
STOKStoke Therapeutics, Inc.$71.3M2.13%3.81%Not reportedQ4 2024
CRNXCrinetics Pharmaceuticals, Inc.$70.2M2.09%1.58%-10.7%Q3 2024
DYNDyne Therapeutics, Inc.$68.5M2.04%2.12%-25.9%Q3 2024
APLSApellis Pharmaceuticals, Inc.$64.8M1.93%2.04%Not reportedQ3 2024
COGTCogent Biosciences, Inc.$57.9M1.73%1.01%-5.5%Q2 2025
SEPNSepterna, Inc.$55.8M1.66%4.46%-9.2%Q4 2024
TSHATaysha Gene Therapies, Inc.$55.7M1.66%3.55%-8.0%Q3 2024
RYTMRhythm Pharmaceuticals, Inc.$53.5M1.60%0.74%Not reportedQ1 2025
ASNDAscendis Pharma A/S$50.3M1.50%0.38%Not reportedQ3 2024
RAPTRAPT Therapeutics, Inc.$46.6M1.39%4.96%+136.9%Q3 2025
TBLATaboola.com Ltd.$46M1.37%2.97%Not reportedQ3 2024
LXRXLexicon Pharmaceuticals, Inc.$44.8M1.34%10.64%Not reportedQ3 2024
ZYMEZymeworks Inc.$44.2M1.32%2.25%NewQ4 2025
SLDBSolid Biosciences Inc.$43.4M1.29%9.74%+3.7%Q3 2024
WVEWave Life Sciences, Inc.$41.7M1.24%1.31%-33.7%Q3 2024
XENEXenon Pharmaceuticals Inc.$36.4M1.09%1.02%Not reportedQ3 2024
DBVTDBV Technologies S.A.$35.6M1.06%1.10%NewQ4 2025
ERASErasca, Inc.$32.6M0.97%3.08%Not reportedQ3 2024
ENGNenGene Therapeutics Inc.$30.1M0.90%4.98%NewQ4 2025
TRVITrevi Therapeutics, Inc.$28.6M0.85%1.78%-9.9%Q4 2024
SYRESpyre Therapeutics, Inc.$26.8M0.80%1.05%+122.1%Q4 2024
MLYSMineralys Therapeutics, Inc.$25.4M0.76%0.86%NewQ4 2025
DNLIDenali Therapeutics Inc.$23.1M0.69%0.89%+70.0%Q3 2024
RELYRemitly Global, Inc.$22.3M0.67%0.77%Not reportedQ3 2024
FULCFulcrum Therapeutics, Inc.$22.1M0.66%2.93%NewQ4 2025
RAPPRapport Therapeutics, Inc.$21.5M0.64%1.48%-32.8%Q3 2024
SLNSilence Therapeutics plc$17.7M0.53%2.05%Not reportedQ3 2024
IHSIHS Holding Ltd$17.6M0.52%0.70%Not reportedQ3 2024
GOSSGossamer Bio, Inc.$16.1M0.48%2.23%Not reportedQ3 2024
UPBUpstream Bio, Inc.$16M0.48%1.08%-25.4%Q4 2024
BCYCBicycle Therapeutics PLC$14.3M0.43%2.90%Not reportedQ4 2024
MNPRMonopar Therapeutics$13.9M0.41%3.17%NewQ4 2025
CGEMCullinan Therapeutics, Inc.$12.4M0.37%1.98%Not reportedQ3 2024
SIONSionna Therapeutics, Inc.$12.3M0.37%0.67%-7.7%Q1 2025
IKTInhibikase Therapeutics, Inc.$12M0.36%4.44%NewQ4 2025
NBPNovaBridge Biosciences$11.9M0.36%1.13%+157.3%Q3 2025
AMZNAmazon Com Inc$11.9M0.35%0.00%-12.0%Q3 2024
Q3 2025Reported Nov 13, 2025115 positions
SRRKScholar Rock Holding Corp$344M13.48%9.33%Not reportedQ3 2024
KYMRKymera Therapeutics, Inc.$194M7.59%4.78%Not reportedQ3 2024
ONCBeOne Medicines Ltd.$168M6.57%0.03%-3.3%Q3 2024
ARWRArrowhead Pharmaceuticals, Inc.$92.1M3.60%1.97%Not reportedQ3 2024
BCAXBicara Therapeutics Inc.$82.4M3.22%9.55%Not reportedQ3 2024
CNTACentessa Pharmaceuticals PLC$78.3M3.06%2.40%-6.7%Q3 2024
CRNXCrinetics Pharmaceuticals, Inc.$70.3M2.75%1.79%Not reportedQ3 2024
EWTXEdgewise Therapeutics, Inc.$63.2M2.47%3.68%+23.3%Q3 2024
IRONDisc Medicine, Inc.$60.4M2.36%2.61%-16.9%Q1 2025
DYNDyne Therapeutics, Inc.$59.8M2.34%3.32%-2.2%Q3 2024
APLSApellis Pharmaceuticals, Inc.$58.3M2.28%2.04%Not reportedQ3 2024
RNAMAvidity Biosciences, Inc.$56M2.19%0.88%+15.8%Q3 2024
STOKStoke Therapeutics, Inc.$52.8M2.07%4.08%Not reportedQ4 2024
LXRXLexicon Pharmaceuticals, Inc.$52.5M2.06%10.64%Not reportedQ3 2024
RYTMRhythm Pharmaceuticals, Inc.$50.5M1.98%0.75%+22.0%Q1 2025
TNGXTango Therapeutics, Inc.$49.4M1.93%5.27%+74.8%Q3 2024
RVMDRevolution Medicines, Inc.$48.7M1.91%0.55%+11.2%Q3 2024
ASNDAscendis Pharma A/S$46.9M1.83%0.39%-4.1%Q3 2024
RZLTRezolute, Inc.$45.8M1.79%5.35%NewQ3 2025
SLDBSolid Biosciences Inc.$45.8M1.79%9.52%Not reportedQ3 2024
SEPNSepterna, Inc.$41.4M1.62%4.93%Not reportedQ4 2024
RCUSArcus Biosciences, Inc.$39.6M1.55%2.72%+80.6%Q3 2024
TSHATaysha Gene Therapies, Inc.$36M1.41%4.02%Not reportedQ3 2024
TBLATaboola.com Ltd.$34M1.33%2.97%Not reportedQ3 2024
XENEXenon Pharmaceuticals Inc.$32.6M1.28%1.05%Not reportedQ3 2024
SLNOSoleno Therapeutics Inc$31.6M1.24%0.87%Not reportedQ4 2024
RAPPRapport Therapeutics, Inc.$31.3M1.22%2.21%+178.4%Q3 2024
GPCRStructure Therapeutics Inc.$28.8M1.12%0.56%NewQ3 2025
WVEWave Life Sciences, Inc.$27.1M1.06%2.31%Not reportedQ3 2024
RELYRemitly Global, Inc.$26.4M1.03%0.77%+214.0%Q3 2024
COGTCogent Biosciences, Inc.$24.8M0.97%1.23%+101.8%Q2 2025
TRVITrevi Therapeutics, Inc.$23.2M0.91%1.98%-35.6%Q4 2024
NAMSNewAmsterdam Pharma Co N.V.$21.8M0.85%0.68%-35.9%Q3 2024
KRROKorro Bio, Inc.$20.1M0.78%4.46%Not reportedQ3 2024
ERASErasca, Inc.$19.1M0.75%3.09%Not reportedQ3 2024
IHSIHS Holding Ltd$16.1M0.63%0.71%Not reportedQ3 2024
QUREuniQure N.V.$16.1M0.63%0.44%NewQ3 2025
BCYCBicycle Therapeutics PLC$15.6M0.61%2.90%Not reportedQ4 2024
SLNSilence Therapeutics plc$15.1M0.59%2.05%Not reportedQ3 2024
RAPTRAPT Therapeutics, Inc.$15M0.59%3.51%NewQ3 2025
UPBUpstream Bio, Inc.$14.8M0.58%1.46%Not reportedQ4 2024
GOSSGossamer Bio, Inc.$13.7M0.54%2.25%Not reportedQ3 2024
AVBPArriVent BioPharma, Inc.$12.9M0.51%1.71%Not reportedQ2 2025
AMZNAmazon Com Inc$12.8M0.50%0.00%+3.5%Q3 2024
ORICOric Pharmaceuticals, Inc.$12.1M0.47%1.04%Not reportedQ3 2024
DNLIDenali Therapeutics Inc.$11.9M0.47%0.56%Not reportedQ3 2024
IONQIonQ, Inc.$10.5M0.41%0.05%Not reportedQ3 2024
SIONSionna Therapeutics, Inc.$9.56M0.37%0.73%Not reportedQ1 2025
CRWDCrowdStrike Holdings, Inc.$9.07M0.35%0.01%Not reportedQ3 2024
MSFTMicrosoft Corp$8.88M0.35%0.00%+6.2%Q3 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.